Managing a range of complex, cross-border mandates, Vinge Advokatfirman KB‘s capital markets offering ranges from high-value ECM matters to novel debt transactions. The firm’s ECM offering includes high-profile IPOs and corporate governance work as well as listing companies on Nasdaq Stockholm, advising listed companies, PE sponsors as well as investment firms and banks. Erik Sjöman co-leads the team, noted for his work on the recapitalisation of SAS. Working alongside is fellow co-head Jesper Schönbeck, who has expertise in complex IPOs and secondary offerings. Within the DCM space, the firm is frequently engaged by fintechs, blue-chip corporates and life science companies, advising on a range of matters including high-yield and green bonds, and handling securitisations in the domestic and international spheres. Mikael Ståhl is a notable name within the team, with experience advising on MTN, EMTN and UMTN programmes. Co-head Mikael Ståhl also has expertise in DCM, working on note issuances and structured finance matters. Anders Strid is another key contact at the firm.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The Vinge team is commercial and pragmatic. They are easy to work with. Uses best practices in proactively providing updates regarding their workstreams on a regular basis.’
- ‘Arvid Weimers is very service-minded and has strong experience from the debt capital markets.’
- ‘Nilufer Nouri was a great support in all administration and made sure all documents were duly signed and administered. She took control of the signing pace and made sure to follow up when needed. August Ahlin was helpful, clear and accessible. He had all the answers needed, and we never had any delays in his response. We felt strong confidence in their work! Arvid Wiemers was also very clear and easy to work with. All meetings felt efficient but well done, and we have great confidence in him and the team.’
- 'They combine deep legal expertise with strong commercial judgment and are always available, making me feel genuinely prioritised.'
- ‘We are very satisfied with the team’s legal expertise, and their understanding of the market is also at a very high level. What makes them truly stand out, however, is that they are not only excellent lawyers but also genuinely solution-oriented. They dare to take a clear position and provide advice that is both practical and actionable.'
- ‘Among the individuals, we would especially highlight Arvid Weimers. He combines deep legal competence with a pragmatic, business-minded approach. What we appreciate most is that Arvid gives clear and confident advice, tailored to our situation, and is not afraid to make a recommendation. He is responsive, easy to work with, and has become a trusted adviser for us.’
Key clients
- Altor Fund III
- Apotea AB
- Axel Johnson AB
- Boliden AB
- Carasent
- Cinclus Pharma Holding AB
- Egetis Therapeutics
- EQT AB
- EQT IX
- Mentimeter AB (publ)
- Oncopeptides AB (publ)
- Pandox
Work highlights
Advised Röko AB (publ) in connection with its listing on Nasdaq Stockholm.
Advised Apotea AB (publ) in connection with its listing on Nasdaq Stockholm.
Advised Svenska Handelsbanken AB and the other lead arrangers in relation to the annual update of Stadshypotek AB’s €20bn Euro Medium Term Covered Note Programme.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Jesper Schönbeck
Practice head
Jesper Schönbeck; Erik Sjöman; Anders Strid; Albert Wållgren
Other key lawyers
Mikael Ståhl; Arvid Weimers; Nilufer Nouri; August Ahlin